Den anbefalede dosis af SUSTIVA i kombination med en PI´er og/ eller NRTI´ere til patienter i alderen 3 - 17 år er beskrevet i tabel 1.
Paediatric patients (3 to 17 years): the recommended dose of SUSTIVA in combination with a PI and/ or NRTIs for patients between 3 and 17 years of age is described in Table 1.